Artivion | CRY


Peers Price Chg Day Year Date
Terumo 2,645.50 20.00 0.76% -0.02% Sep/05
Abbott 132.94 0.13 0.10% 16.68% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
ResMed 277.05 3.24 1.18% 13.23% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Trinity Biotech 1.16 0.01 0.87% -34.46% Sep/05

Indexes Price Day Year Date
US2000 2391 11.44 0.48% 14.33% Sep/05

Artivion Inc traded at $21.64 this Tuesday April 9th. Looking back, over the last four weeks, Artivion lost 8.69 percent. Over the last 12 months, its price rose by 65.06 percent. Looking ahead, we forecast Artivion Inc to be priced at 21.46 by the end of this quarter and at 20.93 in one year, according to Trading Economics global macro models projections and analysts expectations.

CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.